Search results
Download Full Issue. Semaglutide: weighing up the benefits and risks. Joe Moody. Download PDF. More. The landscape of weight loss has changed dramatically. Semaglutide, a GLP-1 receptor analogue, was originally intended to treat diabetes (brand name Ozempic) but has found a new use resulting in rocketing popularity (Wegovy).
Semaglutide has been shown to increase energy expenditure and promote fat burning, leading to reductions in body weight and improvements in body composition. It may also have a positive impact on lipid metabolism, contributing to favorable changes in cholesterol and triglyceride levels.
13 maj 2024 · Here in this prespecified analysis, we examined effects of semaglutide on weight and anthropometric outcomes, safety and tolerability by baseline body mass index (BMI).
2 lip 2024 · Studies have found that semaglutide reduces the risk of major cardiovascular events, including heart attack and stroke, in adults with overweight or obesity who have known cardiovascular disease, both with and without diabetes.
1 lut 2024 · Semaglutide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart or blood vessel disease.
19 lip 2024 · The drug, generically called semaglutide, is modeled after an unassuming gut hormone called glucagonlike peptide 1 (GLP-1), which stimulates insulin production—as well as the feeling of satiety,...
23 cze 2024 · Semaglutide is found to be efficient for weight loss in patients with overweight or obesity with diabetes mellitus (DM). With a wide range of adverse events reported, the efficacy and safety of once-weekly subcutaneous semaglutide in individuals without DM, with overweight or obesity, is unclear.
